NCT03779061View on ClinicalTrials.gov

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

September 20, 2018

Study Completion Date

September 28, 2018

Conditions
Sedation
Interventions
DRUG

Remimazolam Tosilate

Initial dose plus supplemental doses as necessary

DRUG

Propofol

Initial dose plus supplemental doses as necessary

Trial Locations (1)

010

Clinical trial Ethnics Committee of Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03779061 - Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy | Biotech Hunter | Biotech Hunter